Icaritin

Unknown Manufacturer

Icaritin has been used in trials studying the treatment of Solid Tumors, Metastatic Breast Cancer, and Hepatocellular Carcinoma (HCC).

Overview

Icaritin has been used in trials studying the treatment of Solid Tumors, Metastatic Breast Cancer, and Hepatocellular Carcinoma (HCC).

Technical identifiers

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Pharmaceutical composition containing icaritin, icaritin derivatives, salts of icaritin and icaritin derivatives and solubilizer
Applicant: SICHUAN MANSAISI MEDICINE TECH CO LTDPriority: 2016
CN
Application of icaritin
Applicant: THE SECOND AFFILIATED HOSPITAL OF ZUNYI MEDICAL UNIVPriority: 2024
CN
Preparation of icaritin
Applicant: SHENOGEN PHARMA GROUP LTDPriority: 2007
CN
ICARIIN AND ICARITIN DERIVATIVES
Applicant: H LEE MOFFITT CANCER CT & RESPriority: 2016
CN
EP
2 publications
Medical use of icaritin
Applicant: LUNAN PHARMACEUTICAL GROUP CORPPriority: 2020
CN
EP
US
4 publications
Medical application of icaritin
Applicant: UNIV SHANGHAI TRADITIONAL CHINESE MEDICINEPriority: 2021
CN
Dehydrated icaritin intermediate compound
Applicant: SHANGDONG NEW TIME PHARM PRODPriority: 2021
CN
Preparation method of icaritin
Applicant: UNIV CHINA PHARMAPriority: 2025
CN